In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B

INTRODUCTION: Leishmaniasis is a neglected tropical disease, with approximately 1 million new cases and 30,000 deaths reported every year worldwide. Given the lack of adequate medication for treating leishmaniasis, drug repositioning is essential to save time and money when searching for new therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Beatriz Santana, Bueno, Gislayne de Paula, Tomiotto-Pellissier, Fernanda, Figueiredo, Fabiano Borges, Soares Medeiros, Lia Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868945/
https://www.ncbi.nlm.nih.gov/pubmed/36699729
http://dx.doi.org/10.3389/fcimb.2022.1044665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868945/
https://www.ncbi.nlm.nih.gov/pubmed/36699729
http://dx.doi.org/10.3389/fcimb.2022.1044665

Ejemplares similares